Hyloris Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	129	192	183	357	325	447
Market Cap Growth	-31.95%	4.59%	-48.71%	9.91%	-27.32%	82.10%
Enterprise Value	116.64	178.95	163.86	331.4	285.28	408.65
Last Close Price	4.61	6.84	6.54	12.75	11.60	17.30
PS Ratio	16.22	26.57	21.65	171.06	360.89	144.35
PB Ratio	4.87	7.27	5.72	9.14	6.03	9.30
P/TBV Ratio	6.25	9.28	6.50	10.13	6.27	9.91
EV/Sales Ratio	14.69	24.83	19.37	158.79	316.97	131.99
Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.02	0.01
Net Debt / Equity Ratio	-0.48	-0.48	-0.60	-0.66	-0.73	-0.80
Net Debt / EBITDA Ratio	2.13	2.13	2.97	1.64	3.46	3.68
Net Debt / FCF Ratio	1.22	1.80	2.67	1.95	3.01	3.37
Asset Turnover	0.19	0.19	0.19	0.04	0.01	0.04
Inventory Turnover	14.58	14.58	-	-	-	-
Quick Ratio	3.78	3.78	4.05	5.10	8.33	3.53
Current Ratio	3.89	3.89	4.15	5.22	8.63	3.60
Return on Equity (ROE)	-21.61%	-21.61%	-17.81%	-33.08%	-23.35%	-15.96%
Return on Assets (ROA)	-17.21%	-17.21%	-16.02%	-29.50%	-18.75%	-12.80%
Return on Invested Capital (ROIC)	-46.23%	-48.00%	-54.15%	-114.90%	-96.27%	-30.55%
Return on Capital Employed (ROCE)	-21.82%	-21.82%	-18.99%	-33.36%	-22.51%	-13.83%
Buyback Yield / Dilution	-	0.00%	0.00%	-2.95%	-5.29%	-18.40%
Total Shareholder Return	-	0.00%	0.00%	-2.95%	-5.29%	-18.40%